Hepatitis C News and Research

Latest Hepatitis C News and Research

Perceived stigmatization is common among patients with NAFLD, study finds

About seven out of ten patients (69%) who suffer from non-alcoholic fatty liver disease (NAFLD) perceive some stigmatization in their daily life, according to a study led by a team of the University of Barcelona, the Liver and Digestive Diseases Networking Biomedical Research Centre, the Hospital Clínic de Barcelona and the August Pi i Sunyer Biomedical Research Institute.

12 May 2022

Potential indirect and direct effects of SARS-CoV-2 on pancreatic islets in patients who became hyperglycemic after COVID-19

In a recent study published in Diabetes, researchers assessed the direct and indirect effects of SARS-CoV-2 on human pancreatic islets.

5 May 2022

Artificial circular RNAs found to bypass cellular antiviral responses

Researchers produced artificial circular ribonucleic acid sponges in a permuted intron-exon system and showed that these did not activate innate immunity.

29 Apr 2022

CDC issues health alert about children identified with hepatitis and adenovirus infection

CDC today issued a nationwide health alert to notify clinicians and public health authorities about a cluster of children identified with hepatitis and adenovirus infection – and to ask all physicians to be on the lookout for symptoms and to report any suspected cases of hepatitis of unknown origin to their local and state health departments.

26 Apr 2022

New platform for studying how the immune system responds to hepatitis C

A vaccine for hepatitis C has eluded scientists for more than 30 years, for several reasons. For one, the virus that causes the disease comes in many genetic forms, complicating the creation of a widely effective vaccine.

6 Apr 2022

Importance of Numb-associated kinases in SARS-CoV-2 infection

A new study posted to the bioRxiv* preprint server has focussed on assessing four members of the NAK family that are associated with SARS-CoV-2 infection. These kininases could act as a target for the development of effective COVID-19 therapeutics.

23 Mar 2022

Scientists identify a promising strategy for stopping Ebola virus polymerase

To treat Ebola virus infections, researchers are taking a close look at a key piece of the virus: polymerase.

23 Mar 2022

Tracking the mutating coronavirus variants

Viruses continuously and naturally evolve. To track coronavirus variants, we need to think like Darwin.

16 Mar 2022

Canadian scientist discusses about how society could better prepare for future pandemics

Aled Edwards is of two minds about medicine's response to COVID-19. On one hand, he notes, we had life-saving vaccines and therapies less than a year after the discovery of SARS-CoV-2. On the other, more than six million, and possibly as many as 18 million people have died, and global access to advances that can prevent and treat severe disease remains highly inequitable.

11 Mar 2022

Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

Researchers elucidated antiviral activities of aminoglycoside geneticin against seven SARS-CoV-2 variants using different cell lines and respiratory tissues.

11 Mar 2022

Equine hepatitis viruses help gain new insights into the behavior of hepatitis C virus in humans

Research comparing viruses found in humans and horses provides insights that may aid vaccine development.

2 Mar 2022

Study shows the viability of lung transplants in patients with COVID-19-associated ARDS

Patients with COVID-19-associated acute respiratory distress syndrome who received lung transplants had similar outcomes, compared to transplant patients without COVID-19, according to a Northwestern Medicine study published in JAMA.

2 Mar 2022

Outpatient antibiotic treatment for infective endocarditis improves outcomes, reduces costs

A new modeling study suggests that when patients who inject opioids continue an antibiotic treatment for infective endocarditis outside of the hospital, they experienced better long-term health outcomes than patients who receive the standard four to six weeks of inpatient, intravenous antibiotic therapy.

28 Feb 2022

Immunomolecular detection method to rapidly and accurately detect complete SARS-CoV-2 virions

Researchers developed a hybrid assay incorporating immunological antibody-based viral spike protein capture with molecular nucleic acid amplification by qRT-PCR.

24 Feb 2022

Treatment with direct-acting antivirals reduces emergency visits, hospitalizations among hepatitis C patients

Researchers at Henry Ford Health System, as part of a national hepatitis C collaborative, report that patients with chronic hepatitis C who are treated with direct-acting antiviral medicines are less likely to be hospitalized or seek emergency care for liver and non-liver related health issues.

21 Feb 2022

Hepatitis C News and Research

Latest Hepatitis C News and Research

Perceived stigmatization is common among patients with NAFLD, study finds

Potential indirect and direct effects of SARS-CoV-2 on pancreatic islets in patients who became hyperglycemic after COVID-19

Artificial circular RNAs found to bypass cellular antiviral responses

CDC issues health alert about children identified with hepatitis and adenovirus infection

New platform for studying how the immune system responds to hepatitis C

Importance of Numb-associated kinases in SARS-CoV-2 infection

Scientists identify a promising strategy for stopping Ebola virus polymerase

Tracking the mutating coronavirus variants

Canadian scientist discusses about how society could better prepare for future pandemics

Aminoglycoside antibiotic geneticin shows selective antiviral effect against SARS-CoV-2

Equine hepatitis viruses help gain new insights into the behavior of hepatitis C virus in humans

Study shows the viability of lung transplants in patients with COVID-19-associated ARDS

Outpatient antibiotic treatment for infective endocarditis improves outcomes, reduces costs

Immunomolecular detection method to rapidly and accurately detect complete SARS-CoV-2 virions

Treatment with direct-acting antivirals reduces emergency visits, hospitalizations among hepatitis C patients

The impact of SARS-CoV-2 on lipids

The emergence of infectious diseases from the "germ’s eye view”

Liver cirrhosis has higher hospitalization and in-hospital mortality rates in Germany

Researchers develop new tool to determine patients' liver cancer risk after hepatitis C

Two-step strategy can help determine the risk of liver cancer after HCV cure

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Hepatitis C News and Research

Latest Hepatitis C News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in